Literature DB >> 10091820

Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure.

M Metra1, P Faggiano, A D'Aloia, S Nodari, A Gualeni, D Raccagni, L Dei Cas.   

Abstract

OBJECTIVES: We studied whether direct assessment of the hemodynamic response to exercise could improve the prognostic evaluation of patients with heart failure (HF) and identify those in whom the main cause of the reduced functional capacity is related to extracardiac factors.
BACKGROUND: Peak exercise oxygen consumption (VO2) is one of the main prognostic variables in patients with HF, but it is influenced also by many extracardiac factors.
METHODS: Bicycle cardiopulmonary exercise testing with hemodynamic monitoring was performed, in addition to clinical evaluation and radionuclide ventriculography, in 219 consecutive patients with chronic HF (left ventricular ejection fraction, 22 +/- 7%; peak VO2, 14.2 +/- 4.4 ml/kg/min).
RESULTS: During a follow-up of 19 +/- 25 months, 32 patients died and 6 underwent urgent transplantation with a 71% cumulative major event-free 2-year survival. Peak exercise stroke work index (SWI) was the most powerful prognostic variable selected by Cox multivariate analysis, followed by serum sodium and left ventricular ejection fraction, for one-year survival, and peak VO2 and serum sodium for two-year survival. Two-year survival was 54% in the patients with peak exercise SWI < or = 30 g x m/m2 versus 91% in those with a SWI >30 g x m/m2 (p < 0.0001). A significant percentage of patients (41%) had a normal cardiac output response to exercise with an excellent two-year survival (87% vs. 58% in the others) despite a relatively low peak VO2 (15.1 +/- 4.7 ml/kg/min).
CONCLUSIONS: Direct assessment of exercise hemodynamics in patients with HF provides additive independent prognostic information, compared to traditional noninvasive data.

Entities:  

Mesh:

Year:  1999        PMID: 10091820     DOI: 10.1016/s0735-1097(98)00672-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  20 in total

Review 1.  Exercise testing with concurrent beta-blocker usage: is it useful? What do we learn?

Authors:  Eugene E Wolfel
Journal:  Curr Heart Fail Rep       Date:  2006-06

2.  Peak cardiac power measured noninvasively with a bioreactance technique is a predictor of adverse outcomes in patients with advanced heart failure.

Authors:  Hannah Rosenblum; Stephen Helmke; Paula Williams; Sergio Teruya; Margaret Jones; Daniel Burkhoff; Donna Mancini; Mathew S Maurer
Journal:  Congest Heart Fail       Date:  2010-10-19

3.  Unexplained exertional dyspnea caused by low ventricular filling pressures: results from clinical invasive cardiopulmonary exercise testing.

Authors:  William M Oldham; Gregory D Lewis; Alexander R Opotowsky; Aaron B Waxman; David M Systrom
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

4.  Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes.

Authors:  Gregory D Lewis; Ryan M Murphy; Ravi V Shah; Paul P Pappagianopoulos; Rajeev Malhotra; Kenneth D Bloch; David M Systrom; Marc J Semigran
Journal:  Circ Heart Fail       Date:  2011-02-03       Impact factor: 8.790

Review 5.  Clinical Classification of Heart Failure Patients Using Cardiac Function during Exercise.

Authors:  Eric M Snyder; Erik H Van Iterson; Thomas P Olson
Journal:  Exerc Sport Sci Rev       Date:  2015-10       Impact factor: 6.230

6.  Effect of iron overload on exercise capacity in thalassemic patients with heart failure.

Authors:  Sophie Mavrogeni; Efstathios Gotsis; Dimitrios Verganelakis; Eleni Berdousis; Athanasios Dritsas; Genovefa Kolovou; Panagiotis Toulas; Vassilios Ladis
Journal:  Int J Cardiovasc Imaging       Date:  2009-08-13       Impact factor: 2.357

7.  Quantification of the impaired cardiac output response to exercise in heart failure: application of a non-invasive device.

Authors:  Jonathan Myers; Pradeep Gujja; Suresh Neelagaru; Leon Hsu; Daniel Burkhoff
Journal:  J Sports Sci Med       Date:  2009-09-01       Impact factor: 2.988

8.  Ventilatory variables are strong prognostic markers in elderly patients with heart failure.

Authors:  M Mejhert; E Linder-Klingsell; M Edner; T Kahan; H Persson
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

9.  Estimation of cardiac output in patients with congestive heart failure by analysis of right ventricular pressure waveforms.

Authors:  Mustafa Karamanoglu; Tom Bennett; Marcus Ståhlberg; Vincent Splett; Barbro Kjellström; Cecilia Linde; Frieder Braunschweig
Journal:  Biomed Eng Online       Date:  2011-05-13       Impact factor: 2.819

10.  Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials.

Authors:  Marco Metra; Eric Eichhorn; William T Abraham; Jennifer Linseman; Michael Böhm; Ramon Corbalan; David DeMets; Teresa De Marco; Uri Elkayam; Michael Gerber; Michel Komajda; Peter Liu; Vyacheslev Mareev; Sergio V Perrone; Philip Poole-Wilson; Ellen Roecker; Jennifer Stewart; Karl Swedberg; Michal Tendera; Brian Wiens; Michael R Bristow
Journal:  Eur Heart J       Date:  2009-12       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.